Correlation Between Virax Biolabs and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Viracta Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Viracta Therapeutics.
Diversification Opportunities for Virax Biolabs and Viracta Therapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Virax and Viracta is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Viracta Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.91 times more return on investment than Viracta Therapeutics. However, Virax Biolabs is 1.91 times more volatile than Viracta Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 1,190 in Virax Biolabs Group on September 2, 2024 and sell it today you would lose (993.00) from holding Virax Biolabs Group or give up 83.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Viracta Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Viracta Therapeutics |
Virax Biolabs and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Viracta Therapeutics
The main advantage of trading using opposite Virax Biolabs and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Viracta Therapeutics vs. Tff Pharmaceuticals | Viracta Therapeutics vs. Eliem Therapeutics | Viracta Therapeutics vs. Inhibrx | Viracta Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |